Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02494297
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:31.337505+00:00
Published At
2021-08-27T00:00:00+00:00
Record Updated At
2021-08-27
Results Posted At
2021-08-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hirsutism", "Androgenetic Alopecia", "Severe Anemia", "Seborrhea", "PCOS"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-08-27"
protocolSection.identificationModule.nctId
"NCT02494297"
protocolSection.identificationModule.officialTitle
"Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-08-27"

Study condition terms

  • Hirsutism (protocolSection.conditionsModule.conditions)
  • Androgenetic Alopecia (protocolSection.conditionsModule.conditions)
  • Severe Anemia (protocolSection.conditionsModule.conditions)
  • Seborrhea (protocolSection.conditionsModule.conditions)
  • PCOS (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.